FOLD
AMICUS THERAPEUTICS, INC.
Insiders sold $323K net in the last 90 days ·1 seller, 0 buyers· latest Form 4 filed Mar 4, 2026
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$5.4M
reported sales (SEC code S)
Unique Insiders
4
in the rolling window
Latest filing
Apr 27, 2026
Campbell Bradley L
AMICUS THERAPEUTICS, INC. (FOLD) has 32 SEC Form 4 filings (48 transaction rows) in the rolling window, disclosed by 4 distinct insiders. Most recent filing: Apr 27, 2026.
Inside the rolling window, 4 insiders at AMICUS THERAPEUTICS, INC. reported no open-market purchases and 13 open-market sales totaling $5.4M. The most active filer is President and CEO Campbell Bradley L with 5 filings. Insiders have net sold $5.4M over the trailing 6 months. The most recent open-market filing is a sale of 22,500 shares by President and CEO Campbell Bradley L, dated Mar 2, 2026, worth $323K.
- Industry:Biotechnology
- CEO:Bradley L. Campbell
- Employees:499
- HQ:Philadelphia, PA, US
- IPO:2007-05-31
| Source | |||||||
|---|---|---|---|---|---|---|---|
| President and CEO | Sale | 22,500 | $323K | Mar 4 | — | SEC ↗ | |
| President and CEO | Sale | 75,000 | $1.1M | Jan 22 | — | SEC ↗ | |
| Chief People Officer | Sale | 25,642 | $363K | Dec 23 | — | SEC ↗ | |
| President and CEO | Sale | 77,926 | $846K | Dec 17 | — | SEC ↗ | |
| Chief People Officer | Sale | 25,643 | $282K | Dec 17 | — | SEC ↗ | |
| President and CEO | Sale | 14,587 | $146K | Dec 3 | — | SEC ↗ | |
Rosenberg EllenFirst filing | Chief Legal Officer | Sale | 36,000 | $362K | Nov 26 | — | SEC ↗ |
Rosenberg EllenFirst filing | Chief Legal Officer | Sale | 36,000 | $360K | Nov 26 | — | SEC ↗ |
Rosenberg EllenFirst filing | Chief Legal Officer | Sale | 23,621 | $236K | Nov 26 | — | SEC ↗ |
Castelli JeffFirst filing | Chief Development Officer | Sale | 76,158 | $774K | Nov 26 | — | SEC ↗ |
Campbell Bradley LFirst filing | President and CEO | Sale | 14,587 | $147K | Nov 26 | — | SEC ↗ |
| Chief People Officer | Sale | 25,643 | $259K | Nov 26 | — | SEC ↗ | |
Clark David MichaelFirst filing | Chief People Officer | Sale | 25,643 | $244K | Nov 5 | — | SEC ↗ |
Earnings: last 7 quarters
Congress trading FOLD 1 all-time
- DRep. Daniel GoldmanSale$1,001 - $15,0002023-04-10
STOCK Act disclosures are filed up to 45 days after the trade. Amount is a disclosed range, not an exact figure.
Frequently asked questions
How many SEC Form 4 insider filings does FOLD have?
AMICUS THERAPEUTICS, INC. (FOLD) has 32 SEC Form 4 filings (48 transaction rows) in the rolling 365-day window, disclosed by 4 distinct insiders. Most recent filing: Apr 27, 2026.
When was the most recent SEC Form 4 filing for FOLD?
The most recent Form 4 filing for FOLD on Tracefour is dated Apr 27, 2026.
Who is the most active insider at FOLD?
The most active SEC Form 4 filer at FOLD in the rolling window is President and CEO Campbell Bradley L, with 5 filings.
What is the net insider flow at FOLD over the last 6 months?
Over the trailing 180 days, insiders at FOLD have net sold $5.4M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at FOLD in the current window?
Inside the rolling window, insiders at FOLD bought $0 and sold $5.4M based on SEC Form 4 filings.
Can I get alerts for FOLD insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at AMICUS THERAPEUTICS, INC. (FOLD). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.